Hijazi Nermeen, Alourfi Zaynab
Internal Medicine Department-Endocrinology, Damascus University, Damascus, Syria.
Faculty of Medicine, Syrian Private University (SPU), Damascus, Syria.
Adv Med. 2020 Feb 19;2020:7014212. doi: 10.1155/2020/7014212. eCollection 2020.
Osteoporosis and hypertension are frequent and often coexisting diseases among the elderly. Recent studies suggested that both diseases may share the same etiopathology. Moreover, the treatment of hypertension can affect the bone mineral density and worsen osteoporosis. The aim of this cross-sectional study was to assess the prevalence of low bone mass and osteoporosis in postmenopausal Syrian women and investigate their relationship with hypertension and antihypertensive drugs.
813 postmenopausal women were involved in this cross-sectional study, aged between 40 and 96 yrs. Their menopause duration ranged between 1 and 43 yrs. Bone mineral density was measured using a dual-energy X-ray absorptiometry at the total lumbar spine (L1-L4) and left hip. T-score values were used to determine the diagnosis of osteoporosis. The existence of HTN was defined as blood pressure ≥130/85 mmHg or a history of hypertension medication.
Using the world health organization criteria, 24% had osteoporosis and 45.2% had low bone mass. The incidence of osteoporosis and low bone mass significantly increased with age and menopause duration and decreased with BMI. Prevalence of hypertension was almost equal among the women who had or did not have osteoporosis. However, hypertensive women who used thiazides or beta blockers had higher values of total lumbar BMD compared with the women who did not.
Hypertension in postmenopausal Syrian women aged over 40 was not found to be associated with osteoporosis. However, the mean total lumbar BMD of the hypertensive women who took thiazide diuretics or beta blocker was found to be increased significantly comparing to the women who did not take either.
骨质疏松症和高血压在老年人中是常见且常并存的疾病。最近的研究表明,这两种疾病可能具有相同的病因病理。此外,高血压的治疗会影响骨密度并加重骨质疏松症。这项横断面研究的目的是评估叙利亚绝经后女性低骨量和骨质疏松症的患病率,并调查它们与高血压及抗高血压药物的关系。
813名年龄在40至96岁之间的绝经后女性参与了这项横断面研究。她们的绝经持续时间在1至43年之间。使用双能X线吸收法测量腰椎(L1-L4)和左髋部的骨密度。T值用于确定骨质疏松症的诊断。高血压的存在定义为血压≥130/85 mmHg或有高血压用药史。
根据世界卫生组织标准,24%的女性患有骨质疏松症,45.2%的女性有低骨量。骨质疏松症和低骨量的发生率随年龄和绝经持续时间显著增加,随体重指数降低。有或没有骨质疏松症的女性中高血压患病率几乎相等。然而,使用噻嗪类药物或β受体阻滞剂的高血压女性的腰椎总骨密度值高于未使用的女性。
未发现40岁以上叙利亚绝经后女性的高血压与骨质疏松症有关。然而,与未服用噻嗪类利尿剂或β受体阻滞剂的女性相比,服用这些药物的高血压女性的腰椎平均总骨密度显著增加。